Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GBL Gül Biyoloji Laboratuvarı is a Turkey-based healthcare manufacturer focused on in vitro diagnostic products, medical device disinfectants, biocidal products, microscopy reagents, and related laboratory consumables. Founded in 1990 by Dr. Sait Hulusi Özbudun, the company began producing laboratory diagnostic kits in the mid-1990s and medical device disinfectants and biocidal products in 1998. Its commercial portfolio includes hemodialysis machine disinfectants, endoscope and surgical instrument high-level disinfectants, skin and hand disinfectants, microscopy stains, staining sets, chemical reagents, and other laboratory products. GBL operates certified manufacturing under ISO 9001 and ISO 13485 and markets products in Turkey while exporting to multiple international regions. The business appears to be a long-standing private manufacturer rather than a therapeutics developer, with revenue generated from marketed products and laboratory-related services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GBL Gül Biyoloji Laboratuvarı.